Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors

Status:
Completed

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

This is a multicenter, open-label, dose-escalation study to assess the safety, tolerability and Pharmacokinetics of MGFR1877S.

Phase 1

Genentech, Inc.